Chronic kidney disease is a significant public health issue. Nationwide, roughly 37 million Americans live with chronic kidney disease. Each year, more than 130,000 Americans receive a diagnosis of kidney failure or end-stage renal disease, an irreversible condition that can be fatal.
DaVita is one of the largest providers of kidney care, and its services range from slowing the progression of kidney disease to supporting transplantation. This week on "Podnosis," Senior Editor Heather Landi sits down with Misha Palecek, who leads DaVita’s strategic value-based care partnerships and care delivery innovations, to discuss why the shift to value-based care is critical in raising the bar on kidney care and addressing widespread healthcare disparities.
To learn more about the topics in this episode:
-
More than half of Americans are unfamiliar with chronic kidney disease, survey finds
- DaVita, Medtronic raise the curtain on tech company, Mozarc Medical, aiming to bring innovation to kidney care
-
Program promises to take a team approach to tackling severe kidney disease
-
DaVita CEO Javier Rodriguez talks integrated kidney care, competitive threats and regulation
-
Home care industry touts bipartisan bill to expand Medicare in-home benefits, reimbursement